Evidence map›Paper›PMID 30314265›Full record

ArticleInternational journal of molecular sciences2018

Immunomodulatory Effects of the Nutraceutical Garlic Derivative Allicin in the Progression of Diabetic Nephropathy.

Abraham Said Arellano Buendía, Montserrat Tostado González, Omegar Sánchez Reyes, Fernando Enrique García Arroyo, Raúl Argüello García, Edilia Tapia, Laura Gabriela Sánchez Lozada, Horacio Osorio Alonso

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Lebanese Medicinal Plants with Ophthalmic Properties.Pharmaceuticals (Basel, Switzerland) · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Abraham Said Arellano BuendíaRenal Physiopathology Laboratory, Department of Nephrology, Instituto Nacional de Cardiología "Ignacio Chávez" México City 14080, Mexico. neoabraham_7@hotmail.com.
Montserrat Tostado GonzálezRenal Physiopathology Laboratory, Department of Nephrology, Instituto Nacional de Cardiología "Ignacio Chávez" México City 14080, Mexico. pochi859@hotmail.com.
Omegar Sánchez ReyesRenal Physiopathology Laboratory, Department of Nephrology, Instituto Nacional de Cardiología "Ignacio Chávez" México City 14080, Mexico. tuzome_sanrey23@hotmail.com.
Fernando Enrique García ArroyoRenal Physiopathology Laboratory, Department of Nephrology, Instituto Nacional de Cardiología "Ignacio Chávez" México City 14080, Mexico. jonibertojr@hotmail.com.
Raúl Argüello GarcíaDepartamento de Genética y Biología Molecular, Centro de Investigación y de Estudios Avanzados-IPN, México City 07360, Mexico. raularguellogarcia@yahoo.com.
Edilia TapiaRenal Physiopathology Laboratory, Department of Nephrology, Instituto Nacional de Cardiología "Ignacio Chávez" México City 14080, Mexico. ediliatapia@hotmail.com.
Laura Gabriela Sánchez LozadaRenal Physiopathology Laboratory, Department of Nephrology, Instituto Nacional de Cardiología "Ignacio Chávez" México City 14080, Mexico. lgsanchezlozada@gmail.com.
Horacio Osorio AlonsoRenal Physiopathology Laboratory, Department of Nephrology, Instituto Nacional de Cardiología "Ignacio Chávez" México City 14080, Mexico. horacio.osorio@cardiologia.org.mx.ORCID 0000-0002-9238-4202
Instituto Nacional de Cardiología · MXInstituto Politécnico Nacional · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic nephropathy (DN) is presently the primary cause of chronic kidney disease and end-stage renal disease (ESRD). It has been suggested that inflammation and oxidative stress, in addition to or in concert with the metabolic changes, plays an important role in the maintenance and progression of the disease. Therefore, attenuating or blocking these mechanisms may be a therapeutic target to delay the progression of the disease. Diallyl thiosulfinate (allicin), a compound derived from garlic, inhibits free radical formation, increases glutathione synthesis and decreases the levels of proinflammatory molecules in vitro. This research aimed to assess the effect of allicin on oxidative stress and inflammation-induced diabetes. Animals were divided into control and diabetes (streptozotocin 50 mg/kg i.p.), and maintained for 30 days. After 30 days, the group of diabetic animals was subdivided into diabetes and allicin-treated diabetes (16 mg/kg/day oral gavage). The three experimental groups were maintained for another month. We analyzed the status of renal function, oxidative stress and proinflammatory cytokines. The untreated diabetic group showed hyperglycemia and increased diuresis, creatinine clearance, proteinuria, glycosuria and urinary excretion of

Indexed as

Dietary SupplementsAnimalsAntioxidantsBiomarkersBlood GlucoseCreatinineCytokinesDiabetic NephropathiesDisease Models, AnimalDisease ProgressionDisulfidesGarlicGlomerular Filtration RateImmunomodulationInflammation MediatorsKidney Function TestsallicinAntioxidantsBiomarkersBlood GlucoseCreatinineCytokinesDisulfidesInflammation MediatorsPlant ExtractsSulfinic Acidsallicindiabetic nephropathyinflammationoxidative stress

Identifiers

PMID30314265
PMCPMC6212798
OpenAlexW2895786483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.